However, given the observational nature of our study and the single-center design, further multi-center studies are necessary to validate these results and to explore the underlying mechanisms by which resistin may influence in-hospital outcomes in AIS patients. The gene discussed is RETN; the disease is androgen insensitivity syndrome.